Autoantibodies in Multiple Sclerosis Patients Before and During IFN-β1b Treatment: Are They Correlated with the Occurrence of Autoimmune Diseases?
Author:
Affiliation:
1. Clinica Neurologica, Dipartimento di Neuroscienze, Università di Torino, Torino, Italy
2. Divisione di Neurologia, Ospedale di Gallarate, Gallarate, Italy
3. Divisione di Neurologia, Ospedale di Fidenza, Fidenza, Italy
Publisher
Mary Ann Liebert Inc
Subject
Virology,Cell Biology,Immunology
Link
http://www.liebertpub.com/doi/pdf/10.1089/107999002753536220
Reference51 articles.
1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
2. Interferon beta-lb in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
3. Chronic systemic high‐dose recombinant interferon alfa‐2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing‐remitting multiple sclerosis
4. Long term recombinant interferon alpha treatment in MS with special emphasis to side effects
5. Multiple Sclerosis
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis;Autoimmunity Highlights;2020-04-10
2. Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment;Clinics and Research in Hepatology and Gastroenterology;2019-06
3. Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis;Drug Safety;2019-03-04
4. Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients;Expert Opinion on Pharmacotherapy;2018-03-12
5. Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature;Annals of Hepatology;2015-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3